A Canadian company is making waves in the crowded field of metabolic disease treatments. SureNano Science, once focused on food-grade chemicals, is now shifting gears toward pharmaceuticals. Their latest move? A feature in a biotech news outlet highlighting their experimental drug, GEP-44. This pept
Alström syndrome (AS) is a rare genetic condition. It affects about 1 in 10, 000 to 1 in 1, 000, 000 live births. It is caused by changes in the ALMS1 gene. A young girl was diagnosed with AS at age 5. She had a unique change in her ALMS1 gene. This change had not been seen before. It was a homozygo
Obesity drugs like Ozempic and Wegovy are game-changers. They help people shed pounds faster than diet and exercise alone. But quitting these meds can lead to quick weight regain. Research from the University of Oxford found that people who stop GLP-1 drugs often gain back almost a pound every month
